Canadian Pharmaceuticals & Biotech Most Popular Stocks

Apotex Health

Market Cap: CA$7.8b

Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

Curaleaf Holdings

Market Cap: CA$3.5b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bright Minds Biosciences

Market Cap: CA$1.1b

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Knight Therapeutics

Market Cap: CA$915.5m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Vireo Growth

Market Cap: CA$687.2m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Verano Holdings

Market Cap: CA$616.5m

Engages in the cannabis business in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$608.2m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Canopy Growth

Market Cap: CA$583.8m

Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.

Cresco Labs

Market Cap: CA$502.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Spectral Medical

Market Cap: CA$405.1m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Cipher Pharmaceuticals

Market Cap: CA$359.4m

Operates as a specialty pharmaceutical company in Canada.

Vector Science and Therapeutics

Market Cap: CA$340.9m

Develops and sells novel biomechanical devices and active localized drug-delivery platforms.

Aurora Cannabis

Market Cap: CA$331.4m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

Auxly Cannabis Group

Market Cap: CA$309.0m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

TerrAscend

Market Cap: CA$301.9m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cardiol Therapeutics

Market Cap: CA$289.3m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

High Tide

Market Cap: CA$286.5m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Satellos Bioscience

Market Cap: CA$278.7m

A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.

Organigram Global

Market Cap: CA$237.9m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

BioSyent

Market Cap: CA$174.4m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Medexus Pharmaceuticals

Market Cap: CA$168.2m

Operates as a pharmaceutical company in Canada and the United States.

Grown Rogue International

Market Cap: CA$160.0m

Through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States.

Helix BioPharma

Market Cap: CA$142.8m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

HLS Therapeutics

Market Cap: CA$122.0m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

Charlotte's Web Holdings

Market Cap: CA$112.6m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.

ME Therapeutics Holdings

Market Cap: CA$76.0m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Planet 13 Holdings

Market Cap: CA$70.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Vext Science

Market Cap: CA$69.4m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Covalon Technologies

Market Cap: CA$65.2m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

GoldCoast Resource

Market Cap: CA$59.3m

Engages in the exploration of gold deposits in Ghana.

BioNxt Solutions

Market Cap: CA$45.6m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Sona Nanotech

Market Cap: CA$44.2m

Operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.

NurExone Biologic

Market Cap: CA$44.2m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.